Genome Medical Science Project (Toyama), Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Section of Oral Oncology, Department of Oral and Maxillofacial Surgery, Fukuoka Dental College, Fukuoka, Japan.
PLoS One. 2020 Nov 30;15(11):e0241676. doi: 10.1371/journal.pone.0241676. eCollection 2020.
Medication-related osteonecrosis of the jaw (MRONJ) is intractable and severely affects a patient's quality of life. Although many cases of MRONJ have been reported in the past decade, the disease pathophysiology is unclear and there are no evidence-based therapeutic strategies. MRONJ usually features bone inflammation and infection. Prior studies that explored the association between MRONJ and microbial infection used the culture-based approach, which is not applicable to hundreds of unculturable taxa in the human oral microbiome, or 16S ribosomal RNA gene sequencing, which does not provide quantitative information of the abundance of specific taxa, and information of the presence, abundance, and function of specific genes in the microbiome. Here, deep shotgun metagenome sequencing (>10 Gb per sample) of bulk DNA extracted from saliva of MRONJ patients and healthy controls was performed to overcome these limitations. Comparative quantitative analyses of taxonomic and functional composition of these deep metagenomes (initially of 5 patients and 5 healthy controls) revealed an average 10.1% increase of genus Actinomyces and a 33.2% decrease in genus Streptococcus normally predominant in the human oral microbiota. Pan-genome analysis identified genes present exclusively in the MRONJ samples. Further analysis of the reads mapping to the genes in the extended dataset comprising five additional MRONJ samples and publicly available dataset of nine healthy controls resulted in the identification of 31 genes significantly associated with MRONJ. All these genes were encoded by Actinomyces genomic regions. Of these, the top two abundant genes were almost exclusively encoded by Actinomyces among usual taxa in the human oral microbiota. The potential relationships of these key genes with the disease are discussed at molecular level based on the literature. Although the sample size was small, this study will aid future studies to verify the data and characterize these genes in vitro and in vivo to understand the disease mechanisms, develop molecular targeted drugs, and for early stage screening and prognosis prediction.
药物相关性颌骨坏死(MRONJ)是一种难治性疾病,严重影响患者的生活质量。尽管在过去十年中已经报道了许多 MRONJ 病例,但该疾病的病理生理学尚不清楚,也没有基于证据的治疗策略。MRONJ 通常表现为骨炎症和感染。先前研究探索 MRONJ 与微生物感染之间的关联时,使用了基于培养的方法,但该方法不适用于人类口腔微生物组中数以百计的不可培养类群,或 16S 核糖体 RNA 基因测序,因为后者不能提供特定类群丰度的定量信息,也不能提供微生物组中特定基因的存在、丰度和功能信息。在这里,对 MRONJ 患者和健康对照者的唾液中提取的总 DNA 进行了深度 shotgun 宏基因组测序(每个样本>10GB),以克服这些限制。对这些深度宏基因组的分类和功能组成的比较定量分析(最初对 5 名患者和 5 名健康对照者进行了分析)显示,正常情况下在人类口腔微生物群中占优势的放线菌属增加了 10.1%,而链球菌属减少了 33.2%。泛基因组分析鉴定了仅存在于 MRONJ 样本中的基因。对包含另外 5 个 MRONJ 样本的扩展数据集和 9 个健康对照者的公开数据集的读序列进行进一步分析,确定了 31 个与 MRONJ 显著相关的基因。所有这些基因都由放线菌基因组区域编码。在人类口腔微生物群中通常的类群中,这两个最丰富的基因几乎完全由放线菌编码。基于文献,在分子水平上讨论了这些关键基因与疾病的潜在关系。尽管样本量较小,但本研究将有助于未来的研究验证数据,并在体外和体内对这些基因进行表征,以了解疾病机制,开发分子靶向药物,并进行早期阶段的筛查和预后预测。